Uric Acid in vitro diagnostic test REF: 31H0P Recall
Uric Acid in vitro diagnostic test REF: 31H0P
FDA recall Class II
Ongoing
FDA lists this Class II recall for Uric Acid in vitro diagnostic test REF: 31H0P. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2086-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 2, 2026
- FDA report date
- May 13, 2026
- Quantity in commerce
- 59815 units
- Distribution
- See key details
- FDA cause
- No Marketing Application
What is being recalled?
Uric Acid in vitro diagnostic test REF: 31H0P
Affected model & UDI checker
Search the exact identifiers published for Z-2086-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 31H0P | Uric Acid in vitro diagnostic test REF: 31H0P | Check source notice | Not specified |
| Not specified | Uric Acid in vitro diagnostic test REF: 31H0P | Check source notice | 08806141303077 |
FDA code information
UDI: 08806141303077/ Lot: 241023, 250415, 250509, 250617, 250905
Why was this product recalled?
The devices were distributed without required FDA premarket clearance or approval.
What actions did DFI Co., Ltd. take?
On April 2, 2026 Dream Future Innovation (DFI Co., Ltd.) issued a Urgent Medical Device Recall Notification to affected consignees via E. Mail. DFI ask consignees to take the following actions: 4.1 Distribution required Actions 1) Immediate Discontinuation: Immediately stop the use and distribution of the Products. 2) Inventory Quarantine: Quarantine all remaining inventory in a safe place and attach a NOT FOR SALE label. 3) Reply to Acknowledgement: Please fill out the attached Recall Acknowledgement Report and return it within 10 business days of receiving this notice 4) Sub-distributor Notification: Immediately notify all sub-distributors or end customers receiving Products. 4.2 End Customer required Actions 1) Stop using the product immediately. 2) Do not give or sell the product to anyone else. 3) Follow the instructions below regarding destruction or disposal. 4) Submit your refund / confirmation request as instructed. < Destruction / Disposal Instructions > To prevent accidental use, please cut the unused test strip(s) in half. After cutting the strips in half, please dispose of the destroyed components in accordance with your local municipal waste regulations
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2086-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology